Measuring Medical Affairs Performance

While the medical affairs function arguably plays the most crucial role in the success or failure of a pharmaceutical company, investments made to this function are hard to measure in terms of return on investment. This five-page document looks at what tactics top companies are using to measure the efficiency and effectiveness of their medical affairs function. There exists a variety of measures that can be used to gauge performance even if investment is not linked to overall profitability. This document also includes a matrix chart containing medical affairs capabilities and the quantitative and qualitative measures used to assess each.

Key Metrics
Qualitative and quantitative types of measurements in specific medical affairs areas include:
-Overall medical affairs
*A quantitative form of measurement for this area is adherence to budget.
-Medical Research
*For this area, a qualitative type of measurement is feedback from stakeholders on information/data.
-Medical Communications/Writing
*Whether or not the publishing deadlines were met is a quantitative form of measurement for this area.

Methodology
This document results from a Best Practices, LLC consulting project performed on behalf of a pharmaceutical client.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.